Artykuły w czasopismach na temat „Prophylactic ICD-implantation”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „Prophylactic ICD-implantation”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.
Pedersen, Susanne Bendesgaard, Dóra Körmendiné Farkas, Søren Pihlkjær Hjortshøj, Hans Erik Bøtker, Jens Brock Johansen, Berit Thornvig Philbert, Jens Haarbo, Reimar Wernich Thomsen i Jens Cosedis Nielsen. "Significant regional variation in use of implantable cardioverter-defibrillators in Denmark". European Heart Journal - Quality of Care and Clinical Outcomes 5, nr 4 (20.02.2019): 352–60. http://dx.doi.org/10.1093/ehjqcco/qcz008.
Pełny tekst źródłaSacher, Frédéric, Vincent Probst, Dominique Babuty, Frederique Mizon-Gerard, Philippe Maury, Jacques Mansourati, Philippe Mabo i in. "Multicenter study of prophylactic ICD implantation in Brugada syndrome". Heart Rhythm 2, nr 5 (maj 2005): S40. http://dx.doi.org/10.1016/j.hrthm.2005.02.133.
Pełny tekst źródłaBoas, Rune, Nikolay Sappler, Lukas von Stülpnagel, Mathias Klemm, Ulrik Dixen, Jens Jakob Thune, Steen Pehrson i in. "Periodic Repolarization Dynamics Identifies ICD Responders in Nonischemic Cardiomyopathy: A DANISH Substudy". Circulation 145, nr 10 (8.03.2022): 754–64. http://dx.doi.org/10.1161/circulationaha.121.056464.
Pełny tekst źródłaZabel, Markus, Rik Willems, Andrzej Lubinski, Axel Bauer, Josep Brugada, David Conen, Panagiota Flevari i in. "Clinical effectiveness of primary prevention implantable cardioverter-defibrillators: results of the EU-CERT-ICD controlled multicentre cohort study". European Heart Journal 41, nr 36 (6.05.2020): 3437–47. http://dx.doi.org/10.1093/eurheartj/ehaa226.
Pełny tekst źródłaPAISEY, J. "P-494 The prevalence of criteria for prophylactic ICD implantation". Europace 4 (grudzień 2003): B183. http://dx.doi.org/10.1016/s1099-5129(03)92242-2.
Pełny tekst źródłaPaisey, J. R., Y. Yue, K. Elkins, T. Betts, P. R. Roberts i J. M. Morgan. "P-494 The prevalence of criteria for prophylactic ICD implantation". EP Europace 4, Supplement_2 (1.12.2003): B183. http://dx.doi.org/10.1016/eupace/4.supplement_2.b183.
Pełny tekst źródłaSacher, F., J. Mansourati, D. Babuty, V. Probst, M. Salvador, S. Garrigue, P. Sanders, M. Haissaguerre, J. Clementy i H. Le Marec. "434 Multicenter study of prophylactic ICD implantation in Brugada syndrome". EP Europace 7, Supplement_1 (2005): 96–97. http://dx.doi.org/10.1016/eupace/7.supplement_1.96-b.
Pełny tekst źródłaMallavarapu, Vamshi, Bhargavi Degapudi, Monica Williams, Glenn Frazier, Arshneel Kochar, Alaa Shalaby, Francis E. Marchlinski i in. "Outcomes in veteran patients with ischemic cardiomyopathy undergoing prophylactic ICD implantation". Heart Rhythm 2, nr 5 (maj 2005): S282—S283. http://dx.doi.org/10.1016/j.hrthm.2005.02.889.
Pełny tekst źródłaZabel, Markus, Christian Sticherling, Rik Willems, Andrzej Lubinski, Axel Bauer, Leonard Bergau, Frieder Braunschweig i in. "Rationale and design of the EU-CERT-ICD prospective study: comparative effectiveness of prophylactic ICD implantation". ESC Heart Failure 6, nr 1 (9.10.2018): 182–93. http://dx.doi.org/10.1002/ehf2.12367.
Pełny tekst źródłaLuermans, J. G. L. M., M. Mafi Rad i K. Vernooy. "A call for re-evaluation of the guidelines for prophylactic ICD implantation". Netherlands Heart Journal 22, nr 10 (29.08.2014): 429–30. http://dx.doi.org/10.1007/s12471-014-0591-3.
Pełny tekst źródłaZakine, Cyril, Rodrigue Garcia, Kumar Narayanan, Estelle Gandjbakhch, Vincent Algalarrondo, Nicolas Lellouche, Marie-Cécile Perier i in. "Prophylactic implantable cardioverter-defibrillator in the very elderly". EP Europace 21, nr 7 (19.03.2019): 1063–69. http://dx.doi.org/10.1093/europace/euz041.
Pełny tekst źródłaDimitriadis, Zisis, Frank van Buuren, Nikola Bogunovic, Dieter Horstkotte i Lothar Faber. "Marked Regression of Left Ventricular Hypertrophy after Outflow Desobliteration in HOCM". Case Reports in Medicine 2012 (2012): 1–2. http://dx.doi.org/10.1155/2012/546942.
Pełny tekst źródłaTimal, Rohit J., Veronique de Gucht, Joris I. Rotmans, Liselotte C. R. Hensen, Maurits S. Buiten, Mihaly K. de Bie, Hein Putter, Martin J. Schalij, Ton J. Rabelink i J. Wouter Jukema. "The impact of transvenous cardioverter-defibrillator implantation on quality of life, depression and optimism in dialysis patients: report on the secondary outcome of QOL in the randomized controlled ICD2 trial". Quality of Life Research 30, nr 6 (19.02.2021): 1605–17. http://dx.doi.org/10.1007/s11136-020-02744-7.
Pełny tekst źródłaVamos, Mate, Laszlo Saghy i Gabor Bencsik. "Implantation of a VDD implantable cardioverter-defibrillator lead via a persistent left superior vena cava". Herzschrittmachertherapie + Elektrophysiologie 33, nr 1 (6.01.2022): 81–83. http://dx.doi.org/10.1007/s00399-021-00835-7.
Pełny tekst źródłaArgentiero, Adriana, Maria Cristina Carella, Donato Mandunzio, Giulia Greco, Saima Mushtaq, Andrea Baggiano, Fabio Fazzari i in. "Cardiac Magnetic Resonance as Risk Stratification Tool in Non-Ischemic Dilated Cardiomyopathy Referred for Implantable Cardioverter Defibrillator Therapy—State of Art and Perspectives". Journal of Clinical Medicine 12, nr 24 (18.12.2023): 7752. http://dx.doi.org/10.3390/jcm12247752.
Pełny tekst źródłaNodera, Minoru, Hitoshi Suzuki, Yoshiyuki Matsumoto, Masashi Kamioka, Takashi Kaneshiro, Akiomi Yoshihisa , Tetsuya Ohira i Yasuchika Takeishi. "Association between Serum Uric Acid Level and Ventricular Tachyarrhythmia in Heart Failure Patients with Implantable Cardioverter-Defibrillator". Cardiology 140, nr 1 (2018): 47–51. http://dx.doi.org/10.1159/000488851.
Pełny tekst źródłaWichterle, Dan. "Risk Stratification in Post-myocardial Infarction Patients". European Cardiology Review 6, nr 3 (2010): 22. http://dx.doi.org/10.15420/ecr.2010.6.3.22.
Pełny tekst źródłaSCHAER, B. "P-177 Is a prophylactic icd implantation in patients with DCM useful or not?" Europace 4 (grudzień 2003): B108. http://dx.doi.org/10.1016/s1099-5129(03)91929-5.
Pełny tekst źródłaSchaer, B., M. Zellweger, T. Cron i S. Osswald. "P-177 Is a prophylactic icd implantation in patients with DCM useful or not?" EP Europace 4, Supplement_2 (1.12.2003): B108. http://dx.doi.org/10.1016/eupace/4.supplement_2.b108-b.
Pełny tekst źródłaFischer-Rasokat, Ulrich, Matthias Renker, Christoph Liebetrau, Maren Weferling, Andreas Rolf, Andreas Hain, Johannes Sperzel, Yeong-Hoon Choi, Christian W. Hamm i Won-Keun Kim. "Long-Term Survival in Patients with or without Implantable Cardioverter Defibrillator after Transcatheter Aortic Valve Implantation". Journal of Clinical Medicine 10, nr 13 (30.06.2021): 2929. http://dx.doi.org/10.3390/jcm10132929.
Pełny tekst źródłaZabel, Markus, Simon Schlögl, Andrzej Lubinski, Jesper Hastrup Svendsen, Axel Bauer, Elena Arbelo, Sandro Brusich i in. "Present criteria for prophylactic ICD implantation: Insights from the EU-CERT-ICD (Comparative Effectiveness Research to Assess the Use of Primary ProphylacTic Implantable Cardioverter Defibrillators in EUrope) project". Journal of Electrocardiology 57 (listopad 2019): S34—S39. http://dx.doi.org/10.1016/j.jelectrocard.2019.09.001.
Pełny tekst źródłaNaegele, H., M. A. Castel, G. Groth, F. M. Wagner i H. H. Reichenspurner. "Sudden death in patients evaluated for heart transplantation: HFSS detects possible candidates for prophylactic ICD implantation". Journal of Heart and Lung Transplantation 23, nr 2 (luty 2004): S57. http://dx.doi.org/10.1016/j.healun.2003.11.046.
Pełny tekst źródłaHaanschoten, Danielle, i Arif Elvan. "The DAPA Trial in the Context of Previous Prophylactic ICD Landmark Trials". Arrhythmia & Electrophysiology Review 10, nr 3 (27.10.2021): 154–58. http://dx.doi.org/10.15420/aer.2021.23.
Pełny tekst źródłaVersteeg, Henneke, Ivy Timmermans, Jos Widdershoven, Geert-Jan Kimman, Sébastien Prevot, Thomas Rauwolf, Marcoen F. Scholten i in. "Effect of remote monitoring on patient-reported outcomes in European heart failure patients with an implantable cardioverter-defibrillator: primary results of the REMOTE-CIED randomized trial". EP Europace 21, nr 9 (5.06.2019): 1360–68. http://dx.doi.org/10.1093/europace/euz140.
Pełny tekst źródłaFrydensberg, Vivi Skibdal, Jens Brock Johansen, Sören Möller, Sam Riahi, Sonja Wehberg, Jens Haarbo, Berit Thornvig Philbert i in. "Anxiety and depression symptoms in Danish patients with an implantable cardioverter-defibrillator: prevalence and association with indication and sex up to 2 years of follow-up (data from the national DEFIB-WOMEN study)". EP Europace 22, nr 12 (27.10.2020): 1830–40. http://dx.doi.org/10.1093/europace/euaa176.
Pełny tekst źródłaOebel, SR, S. Hilbert, L. Ueberham, J. Kosiuk, S. Richter, M. Doering, A. Bollmann i in. "P1747Risk stratification by CMR imaging for patients undergoing primary prophylactic ICD implantation - Differences between ischemic and non- ischemic etiology". EP Europace 19, suppl_3 (czerwiec 2017): iii382. http://dx.doi.org/10.1093/ehjci/eux161.057.
Pełny tekst źródłaKleemann, T., M. Strauss, K. Kouraki, N. Werner i R. Zahn. "P463Risk assessment for primary prophylactic ICD implantation in hypertrophic cardiomyopathy using the risk calculator: discrepancy between theory and clinical practice?" EP Europace 20, suppl_1 (1.03.2018): i92—i93. http://dx.doi.org/10.1093/europace/euy015.272.
Pełny tekst źródłaWaezsada, Elias, Julie Hutter, Patrick Kahle, Joerg Yogarajah, Johannes Sperzel, Malte Kuniss, Thomas Neumann, Horst Esser, Christian Hamm i Andreas Hain. "Guideline Directed Medical Therapy at Discharge and Further Uptitration Leading to Reduction in Indication for Prophylactic ICD Implantation during Protected Waiting Period". Journal of Clinical Medicine 11, nr 20 (18.10.2022): 6122. http://dx.doi.org/10.3390/jcm11206122.
Pełny tekst źródłaSilka, Michael J., i Yaniv Bar-Cohen. "Should patients with congenital heart disease and a systemic ventricular ejection fraction less than 30% undergo prophylactic implantation of an ICD?" Circulation: Arrhythmia and Electrophysiology 1, nr 4 (październik 2008): 298–306. http://dx.doi.org/10.1161/circep.108.801522.
Pełny tekst źródłaTriedman, John K. "Should patients with congenital heart disease and a systemic ventricular ejection fraction less than 30% undergo prophylactic implantation of an ICD?" Circulation: Arrhythmia and Electrophysiology 1, nr 4 (październik 2008): 307–16. http://dx.doi.org/10.1161/circep.108.805903.
Pełny tekst źródłavon Stülpnagel, Lukas, Bernhard Wolf i Axel Bauer. "Biosignal-guided personalized therapy". Current Directions in Biomedical Engineering 3, nr 2 (7.09.2017): 179–81. http://dx.doi.org/10.1515/cdbme-2017-0037.
Pełny tekst źródłaOebel, SR, S. Hilbert, L. Ueberham, J. Kosiuk, S. Richter, M. Doering, A. Bollmann i in. "P1746Risk stratification for patients undergoing primary prophylactic ICD implantation- the role of CMR imaging for predicting new onset ventricular arrhythmias and death". EP Europace 19, suppl_3 (czerwiec 2017): iii381—iii382. http://dx.doi.org/10.1093/ehjci/eux161.056.
Pełny tekst źródłaFaber, Lothar. "Percutaneous Septal Ablation in Hypertrophic Obstructive Cardiomyopathy: From Experiment to Standard of Care". Advances in Medicine 2014 (2014): 1–14. http://dx.doi.org/10.1155/2014/464851.
Pełny tekst źródłaForleo, Giovanni B., Francesco Solimene, Ennio C. Pisanò, Gabriele Zanotto, Valeria Calvi, Carlo Pignalberi, Giampiero Maglia i in. "Long‐term outcomes after prophylactic ICD and CRT‐D implantation in nonischemic patients: Analysis from a nationwide database of daily remote‐monitoring transmissions". Journal of Cardiovascular Electrophysiology 30, nr 9 (18.06.2019): 1626–35. http://dx.doi.org/10.1111/jce.14006.
Pełny tekst źródłaSantangeli, Pasquale, Luigi Di Biase, Eloisa Basile, Amin Al-Ahmad i Andrea Natale. "Outcomes in Women Undergoing Electrophysiological Procedures". Arrhythmia & Electrophysiology Review 2, nr 1 (2013): 41. http://dx.doi.org/10.15420/aer.2013.2.1.41.
Pełny tekst źródłaBriasoulis, Alexandros, Christos Kourek, Adamantia Papamichail, Konstantinos Loritis, Dimitrios Bampatsias, Evangelos Repasos, Andrew Xanthopoulos, Elias Tsougos i Ioannis Paraskevaidis. "Arrhythmias in Patients with Cardiac Amyloidosis: A Comprehensive Review on Clinical Management and Devices". Journal of Cardiovascular Development and Disease 10, nr 8 (5.08.2023): 337. http://dx.doi.org/10.3390/jcdd10080337.
Pełny tekst źródłaKlein, Helmut U., Michael Block, Heinz Voeller, Wolfram Kamke, Thomas Fetsch, Andreas Suciu i Klaus Contzen. "Prophylactic ICD-implantation in real life 2 years after MADIT II unmasked by the prevention of sudden cardiac death II - registry: Only few patients receive ICDs". Heart Rhythm 2, nr 5 (maj 2005): S243—S244. http://dx.doi.org/10.1016/j.hrthm.2005.02.762.
Pełny tekst źródłaHeidbuchel, Hein, Rik Willems, Luc Jordaens, Brian Olshansky, Francois Carre, Ignacio F. Lozano, Matthias Wilhelm i in. "Intensive recreational athletes in the prospective multinational ICD Sports Safety Registry: Results from the European cohort". European Journal of Preventive Cardiology 26, nr 7 (27.02.2019): 764–75. http://dx.doi.org/10.1177/2047487319834852.
Pełny tekst źródłaLewenhardt, Marie, Fabienne Kreimer, Assem Aweimer, Andreas Pflaumbaum, Andreas Mügge i Michael Gotzmann. "Benefit of primary and secondary prophylactic implantable cardioverter defibrillator in elderly patients". Clinical Cardiology, 14.11.2023. http://dx.doi.org/10.1002/clc.24191.
Pełny tekst źródłaSams, L. E., M. Klemm, M. Woerndl, L. Bachinger, L. E. Villegas Sierra, S. Massberg i K. D. Rizas. "Periodic Repolarization Dynamics (PRD) identifies patients who profit from ICD implantation, A meta-analysis of the predictive value of PRD". European Heart Journal 44, Supplement_2 (listopad 2023). http://dx.doi.org/10.1093/eurheartj/ehad655.681.
Pełny tekst źródłaMigliore, Federico, Nicolò Martini, Leonardo Calo', Annamaria Martino, Giulia Winnicki, Riccardo Vio, Chiara Condello i in. "Predictors of late arrhythmic events after generator replacement in Brugada syndrome treated with prophylactic ICD". Frontiers in Cardiovascular Medicine 9 (22.07.2022). http://dx.doi.org/10.3389/fcvm.2022.964694.
Pełny tekst źródłaKleemann, T., K. Kouraki, M. Strauss, O. Mohammad, A. Wenz i R. Zahn. "Incidence of ventricular tachyarrhythmias and clinical outcomes in primary prophylactic ICD patients in relation to localization of myocardial infarction". Europace 25, Supplement_1 (24.05.2023). http://dx.doi.org/10.1093/europace/euad122.308.
Pełny tekst źródłaKristen, Arnt V., Thomas J. Dengler, Ute Hegenbart, Stefan O. Schonland, Falk-Udo Sack, Frederick Voss, Rüdiger Becker, Hugo A. Katus i Alexander Bauer. "Abstract 1657: Prophylactic Implantation Of Cardioverter Defibrillators In Patients With Severe Cardiac Amyloidosis". Circulation 116, suppl_16 (16.10.2007). http://dx.doi.org/10.1161/circ.116.suppl_16.ii_347-c.
Pełny tekst źródłaYang, P. S., Y. Kang, J. H. Sung, H. D. Park i B. Joung. "Survival among ischemic and non-ischemic heart failure patients with primary implantable cardioverter defibrillator therapy in Korea: a nationwide cohort study". European Heart Journal 42, Supplement_1 (1.10.2021). http://dx.doi.org/10.1093/eurheartj/ehab724.0698.
Pełny tekst źródłaKawahara, Yusei, Hisanori Kanazawa, Seiji Takashio, Yuichiro Tsuruta, Hitoshi Sumi, Takuya Kiyama, Shozo Kaneko i in. "Clinical, electrocardiographic, and echocardiographic parameters associated with the development of pacing and implantable cardioverter-defibrillator indication in patients with transthyretin amyloid cardiomyopathy". Europace, 26.04.2023. http://dx.doi.org/10.1093/europace/euad105.
Pełny tekst źródła"434 Multicenter study of prophylactic ICD implantation in Brugada syndrome". Europace 7 (czerwiec 2005): 96–97. http://dx.doi.org/10.1016/s1099-5129(05)80286-7.
Pełny tekst źródłaAlhakak, A., L. Ostergaard, J. H. Butt, M. Vinther, B. T. Philbert, P. K. Jacobsen, J. K. Petersen i in. "Mortality after implantable cardioverter defibrillators in dialysis patients: a nationwide study". European Heart Journal 41, Supplement_2 (1.11.2020). http://dx.doi.org/10.1093/ehjci/ehaa946.0791.
Pełny tekst źródłaGama, F., M. S. Carvalho, G. Rodrigues, F. M. Costa, D. Matos, J. Carmo, F. Mendes i in. "Idiopathic HFrEF. Is there room left for defibrillators?" European Heart Journal 41, Supplement_2 (1.11.2020). http://dx.doi.org/10.1093/ehjci/ehaa946.0727.
Pełny tekst źródłaZheng, C., A. H. Christensen, C. Joens, N. Risum, H. S. Bosselmann, B. T. Philbert, R. Frosted i H. Bundgaard. "Marked differences in ICD therapy frequencies between phenotypes". European Heart Journal 44, Supplement_2 (listopad 2023). http://dx.doi.org/10.1093/eurheartj/ehad655.685.
Pełny tekst źródłaPelli, Ari, M. Juhani Junttila, Tuomas V. Kenttä, Simon Schlögl, Markus Zabel, Marek Malik, Tobias Reichlin i in. "Q waves are the strongest electrocardiographic variable associated with primary prophylactic implantable cardioverter-defibrillator benefit: a prospective multicentre study". EP Europace, 29.11.2021. http://dx.doi.org/10.1093/europace/euab260.
Pełny tekst źródła